1. Home
  2. ABR vs ACHV Comparison

ABR vs ACHV Comparison

Compare ABR & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$4.05

Market Cap

809.7M

Sector

Real Estate

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$7.55

Market Cap

726.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
ACHV
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
809.7M
726.5M
IPO Year
2003
2018

Fundamental Metrics

Financial Performance
Metric
ABR
ACHV
Price
$4.05
$7.55
Analyst Decision
Hold
Strong Buy
Analyst Count
5
3
Target Price
$9.90
★ $14.67
AVG Volume (30 Days)
★ 4.1M
1.4M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
★ 15.42%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.06
$2.62
52 Week High
$12.58
$8.64

Technical Indicators

Market Signals
Indicator
ABR
ACHV
Relative Strength Index (RSI) 23.12 47.78
Support Level N/A $7.01
Resistance Level $5.41 $8.63
Average True Range (ATR) 0.16 0.39
MACD -0.07 -0.04
Stochastic Oscillator 2.06 37.94

Price Performance

Historical Comparison
ABR
ACHV

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: